Stock & Company Details
Novo-Nordisk A/S $NVO
Price:
46,691,331
3.4B
$209B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
NVO technical indicators
Latest Novo-Nordisk A/S (NVO) indicator readings as of 2026-08-10.
NVO's 14-day RSI is 49.5, in neutral territory. At $47.73 it is trading 2.3% above its 200-day moving average of $46.66, and above its 50-day average of $47.00. Price sits in the middle of its Bollinger Bands ($44.40 to $52.94). ADX reads 21.8, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Novo Nordisk (NVO) is a global healthcare leader focused on diabetes care, obesity treatments, and rare disease therapies. Headquartered in Denmark, the company develops innovative GLP-1 and insulin products that serve millions of patients worldwide. With strong growth driven by demand for weight-loss and metabolic treatments, NVO combines consistent revenue expansion, high margins, and significant investment in research and development.
Finance Bot
Ask your questions
Start by typing a question below.
